Breast Neoplasms: all 12,820 studies

Page 28 of 129. Open to participants first (2,923), then studies with results posted, then the rest; newest registration first within each.

• Evaluation for the Effectiveness and Safety of Cryo-ablation in the Treatment of Early Invasive Breast CancerRecruitingNCT04334785Not applicable
• Abemaciclib and Endocrine Therapy in Older Patients With Breast Cancer.RecruitingNCT04305834Phase 2
• Metronomic Oral Chemotherapy With Cyclophosphamide, Capecitabine and Vinorelbine in Metastatic Breast Cancer PatientsRecruitingNCT04304352Phase 2
• to Evaluate Efficacy and Safety of HLX10 in Combination With Chemotherapy Versus Placebo in Combination With Chemotherapy as Neoadjuvant Therapy and HLX10 Versus Placebo as Adjuvant Therapy in Patients With Triple Negative Breast Cancer (TNBC)Not yet recruitingNCT04301739Phase 3
• Omission of Surgery and Sentinel Lymph Node Dissection in Clinically Low-risk HER2positive Breast Cancer With High HER2 Addiction and a Complete Response Following Standard Anti- HER2-based Neoadjuvant Therapy (ELPIS Trial)Not yet recruitingNCT04301375Phase 2
• Brain Health in Breast Cancer SurvivorsRecruitingNCT04297020
• A Study of Fluzoparib±Apatinib Versus Chemotherapy Treatment of Physician's Choice in HER2-negative Metastatic Breast Cancer Patients With Germline BRCA MutationRecruitingNCT04296370Phase 3
• Refusal of Breast Surgery in Patients With Breast Cancer With a Clinical Complete Response (cCR) After Neoadjuvant Systemic Therapy and a Confirmed Pathological Complete Response (pCR) Using Vacuum-assisted Biopsy (VAB) and Sentinel Lymph Node Biopsy (SLNB)RecruitingNCT04293796Not applicable
• The DBCG Proton Trial: Photon Versus Proton Radiation Therapy for Early Breast CancerRecruitingNCT04291378Not applicable
• Intelligent Vacuum Assisted Biopsy Immediately Before Surgery As an Intra- or Pre-Operative Surrogate for Patient Response to Neoadjuvant Chemotherapy for Breast CancerRecruitingNCT04289935Not applicable
• Clinical Database of Safe Personalized Adjuvant Breast Radiotherapy Based on Individual RadiosensitivityRecruitingNCT04282122
• A Study of BPI-1178 in Patients With Advanced Solid Tumor and HR+/HER2- Breast CancerRecruitingNCT04282031Phase 1/2
• Markers to Evaluate the Efficacy of PH-based Regimen as a Neoadjuvant Therapy for Operable HER2 Positive Breast CancerRecruitingNCT04281641Not applicable
• Clinical High and Genomic Low Hormone Receptor-positive Early Breast Cancer Patients With or Without Adjuvant ChemotherapyRecruitingNCT04278469Not applicable
• Investigating the Effects of Atezolizumab in People Whose Tumour DNA or RNA Indicates Possible SensitivityRecruitingNCT04273061Phase 2
• ScreenIng of Genetic Susceptibility Genes for Breast Cancer Patients in CHinese communiTiesRecruitingNCT04265937
• Bortezomib Followed by Pembrolizumab and Cisplatin in metTNBCRecruitingNCT04265872Early Phase 1
• Fulvestrant Versus Capecitabine as Maintenance Therapy After First-line Chemotherapy in Patients With HR+/HER2- Metastatic Breast CancerRecruitingNCT04263298Phase 3
• NeoRad Breast Cancer StudyRecruitingNCT04261244Phase 3
• GammaPod Dose Escalation Radiation for Early Stage Breast CancerRecruitingNCT04234386Not applicable
• Avoiding Sentinel Lymph Node Biopsy in Breast Cancer Patients After Neoadjuvant ChemotherapyNot yet recruitingNCT04225858Not applicable
• A Clinical Trial of Breast Cancer Neo-adjuvant Therapy Based on Molecular Pathway in FUSCCRecruitingNCT04215003Phase 1/2
• Prospective Cohort Study of Breast Cancer Patients Treated With RadiotherapyEnrolling by invitationNCT04203849
• Health-Related Quality of Life Coupled With Therapeutic Information on Compliance to Endocrine Therapy in Breast CancerRecruitingNCT04176809Not applicable
• Feasibility of Online MR-guided Radiotherapy on a 1.5T MR-LinacRecruitingNCT04172753Not applicable
• Evaluation of Prognostic Factors: From Breast Cancer to Bone MetastasesRecruitingNCT04167605
• Immune Induction Strategies to Improve Response to Immune Checkpoint Blockade in Triple Negative Breast Cancer (TNBC) PatientsRecruitingNCT04159818Phase 2
• Adjuvant Dual Anti-HER2 Therapy in Patients With Small, Node-negative, HER2-positive Breast CancerNot yet recruitingNCT04158856Phase 2
• Radical Local vs. Palliative Therapy for Breast Cancer Patientts With Ipsilateral Humerus or Sternum OligometastasisRecruitingNCT04158843Not applicable
• SHARON: A Clinical Trial for Metastatic Cancer Using Chemotherapy and Patients' Own Stem CellsRecruitingNCT04150042Phase 1
• Evaluation of Prognostic Monitoring for Young Breast Cancer PatientsRecruitingNCT04145986
• Evaluation of Prognostic Monitoring for Breast Cancer Patients With Recurrence and Metastasis After SurgeryRecruitingNCT04145973
• Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Breast CancerRecruitingNCT04145960
• Protein Needs StudyRecruitingNCT04144907Not applicable
• Nab-paclitaxel Plus Carboplatin Versus Nab-paclitaxel Plus Epirubicin in the Neoadjuvant Therapy for Breast CancerRecruitingNCT04138719Phase 2
• Treatment of Triple-negative Breast Cancer With Albumin-bound Paclitaxel as Neoadjuvant Therapy: a Prospective RCTRecruitingNCT04137653Phase 3
• Palbociclib + Letrozole Versus Epirubicin + Cyclophosphamide and Sequential Docetaxel as Neoadjuvant ChemotherapyNot yet recruitingNCT04137640Phase 4
• Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast CancerRecruitingNCT04136782Phase 4
• Ultrasound Imaging and Spectroscopy as Early Indicators of Locally-Advanced Breast Cancer ResponseRecruitingNCT04134780
• Gene Modified Immune Cells After Conditioning Regimen for the Treatment of Stage IIIC or IV Melanoma or Metastatic Solid TumorsRecruitingNCT04119024Phase 1
• Omitting Biopsy of SEntinel Lymph Node With Radiation After Neoadjuvant Chemotherapy in Breast Cancer (OBSERB) TrialNot yet recruitingNCT04116125Not applicable
• Axillary Management in Breast Cancer Patients With Needle Biopsy Proven Nodal Metastases After Neoadjuvant ChemotherapyRecruitingNCT04109079Not applicable
• Accelerated Partial Irradiation of the Breast: New Altered FractionationRecruitingNCT04101656
• Molecular Profiling in Young (<50 Years of Age) Patients With Metastatic Breast CancerEnrolling by invitationNCT04098640Not applicable
• BLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of BreastAvailableNCT04091295
• Olaparib With Cediranib or AZD6738 for the Treatment of Advanced or Metastatic Germline BRCA Mutated Breast CancerRecruitingNCT04090567Phase 2
• Managed Access Programs for BYL719, AlpelisibAvailableNCT04085653
• Study of 3-Day Partial Breast Radiation Therapy in Women With Breast CancerRecruitingNCT04084730Phase 2
• The Breast Cancer Personalized Nutrition StudyRecruitingNCT04079270Not applicable
• BreCLIM-2 - A RCT Investigating Local Treatment for Breast Cancer Liver MetastasesRecruitingNCT04079049Phase 3
• Patterns of Breast Cancer Management and Prognosis of Breast Cancer in ChinaNot yet recruitingNCT04076111
• The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac StudyRecruitingNCT04075305
• Prospective Breast Cancer Biospecimen CollectionRecruitingNCT04074720
• RecurIndex Guided Avoidance of Regional Nodal Irradiation for Node Positive Breast CancerRecruitingNCT04069884Not applicable
• Circulating Tumor Cell Detection in Patients With Luminal A Breast CancerRecruitingNCT04065321
• DFS and QOL After Modified Radical Mastectomy vs. Expanded Mckissock Surgery for EIC of the BreastRecruitingNCT04052893Not applicable
• Use of Quantitative Ultrasound to Guide Adaptive Chemotherapy Among Women With Breast CancerRecruitingNCT04050228Not applicable
• Perioperative Mindfulness ProposalRecruitingNCT04049214Not applicable
• Fecal Microbiota Transplantation in Treating Immune-Checkpoint Inhibitor Induced-Diarrhea or Colitis in Genitourinary Cancer PatientsRecruitingNCT04038619Phase 1
• Comparative Study for the Degree of Biological Changes After Short-term 2 Weeks and 4 Weeks Preoperative Endocrine Therapy in Luminal Breast CancerRecruitingNCT04023292Phase 2
• Myeloid-Derived Suppressor Cell Function in Breast Cancer PatientsRecruitingNCT04022616
• Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)RecruitingNCT04020575Phase 1
• Breast Cancer: Axillary Conservation After Neoadjuvant Chemotherapy in Micro Metastatic Sentinel Lymph Nodes.RecruitingNCT04019678Not applicable
• MRI Radiomics Assessing Neoadjuvant Chemotherapy in Breast Cancer to Predict Lymph Node Metastasis and Prognosis(RBC-02)RecruitingNCT04004559
• Negative Pressure Wound Therapy in Healing Abdominal Incision in Obese Patients Undergoing Breast Reconstruction SurgeryRecruitingNCT04003038Not applicable
• Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical TrialRecruitingNCT03990896Phase 2
• Efficacy of Point Of Service Testing in MBCRecruitingNCT03983577Not applicable
• Erector Spinae Block vs. Placebo Block StudyNot yet recruitingNCT03978780Not applicable
• Pembrolizumab and Oral Metronomic Cyclophosphamide in Patients With Chest Wall Breast CancerRecruitingNCT03971045Phase 2
• High-Resolution Lower Dose Dedicated Breast Computed Tomography (CT)RecruitingNCT03954431Not applicable
• Sodium (23Na) MRI for Tumour Characterisation and Assessment of Therapy Response in Breast CancerRecruitingNCT03940092
• Real-Time MRI-Guided 3-Fraction Accelerated Partial Breast Irradiation in Early Breast CancerRecruitingNCT03936478Phase 2
• Study Comparing 4 Cycles With 6 Cycles of TC (Docetaxel+Cyclophosphamide) Adjuvant Chemotherapy for 1-3 Lymph Node Positive ER+/HER2- Early Breast CancerRecruitingNCT03926091Phase 3
• Repeatability of 68-GaNOTA-Anti-HER2 VHH1 PET/CT in Breast Carcinoma PatientsRecruitingNCT03924466Phase 2
• Next-Generation Sequencing-based Germline and Somatic Genetic Testing in Triple-negative Breast CancerRecruitingNCT03920488
• A Window of Opportunity Study of Pre-operative Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Breast Hormone Receptor Positive (HR+) Human Epidermal Receptor 2 Negative (HER2-) Breast Cancer.RecruitingNCT03906669Phase 2
• Photoacoustic Imaging of the Breast in Patients With Breast Cancer and Healthy SubjectsRecruitingNCT03897270Not applicable
• Enabling the Study of Metabolism in Breast Cancer Through Collection of Fresh-tissue BiopsiesNot yet recruitingNCT03880097
• MACSSI (MAstectomie Cellules Souches Surveillance Immunitaire)RecruitingNCT03870802
• Metastatic Breast Cancer in AustriaRecruitingNCT03870620
• [18F] F-GLN by PET/CT in Breast CancerRecruitingNCT03863457Phase 1
• Establishment and Clinical Application of Precise SLNB System in Breast Cancer: a Randomized, Multicenter, Controlled StudyRecruitingNCT03857932Not applicable
• A Study to Evaluate the Efficacy and Safety of Oral Navelbine in Female Patients With HER2-Negative Metastatic Breast CancerNot yet recruitingNCT03854617Phase 2
• Hypofractionated Irradiation At Regional Nodal Area for Breast Cancer Vs Existed Standard TreatmentRecruitingNCT03829553Phase 3
• HERPET- A Novel PET Imaging Study of HER2 in Breast CancerRecruitingNCT03827317Not applicable
• Intravital Microscopy in Human Solid TumorsRecruitingNCT03823144Not applicable
• Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IORecruitingNCT03815890Phase 2
• Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of DiseaseRecruitingNCT03808337Phase 2
• Converting HR+ Breast Cancer Into an Individualized VaccineRecruitingNCT03804944Phase 2
• Magseed Enabled Long-Term Localization of Axillary Lymph NodesRecruitingNCT03796559Not applicable
• One Week Versus Three Week in Adjuvant Radiotherapy in Breast CancerRecruitingNCT03788213Not applicable
• Harnessing Analysis RNA Expression and Molecular Subtype to Optimize Novel TherapY MBCARecruitingNCT03769415Not applicable
• Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic MalignanciesEnrolling by invitationNCT03762733
• Sweden Cancerome Analysis Network - Breast Recurrence (SCAN-B-rec)RecruitingNCT03758976
• Trans-Artery/Intra-Tumor Infusion of Checkpoint Inhibitors Plus Chemodrug for Immunotherapy of Advanced Solid TumorsRecruitingNCT03755739Phase 2/3
• Local Treatment in ER-positive/HER2-negative Oligo-metastatic Breast CancerRecruitingNCT03750396Phase 2
• PHOENIX DDR/Anti-PD-L1 Trial: A Pre-surgical Window of Opportunity and Post-surgical Adjuvant Biomarker Study of DNA Damage Response Inhibition With or Without Anti-PD-L1 Immunotherapy in Patients With Neoadjuvant Treatment Resistant Residual Triple Negative Breast CancerRecruitingNCT03740893Phase 2
• Binary Oncolytic Adenovirus in Combination With HER2-Specific Autologous CAR VST, Advanced HER2 Positive Solid TumorsRecruitingNCT03740256Phase 1
• Delayed-immediate Versus Delayed Breast Reconstruction in Breast Cancer Patients With Mastectomy and Radiation TherapyRecruitingNCT03730922Not applicable
• A Multi-Modality Surveillance Program for Women at High Risk for Breast CancerRecruitingNCT03729115Not applicable

← Breast Neoplasms overview